During the past decade, OU Jaanson & Laane (EE0002) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "OU Jaanson & Laane (EE0002)" are "Major Depressive Disorder" (2 trials) and "Schizophrenia" (2 trials). Many other conditions were trialed in "OU Jaanson & Laane (EE0002)" in a lesser frequency.

Most popular intervention types in "OU Jaanson & Laane (EE0002)" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Antidepressant + Placebo" (1 trials), "Antidepressant + SPD489 (Lisdexamfetamine dimesylate )" (1 trials), "Lu AF11167" (1 trials), "Lu AF11167 (1-2 mg/day)" (1 trials) and "Lu AF11167 (3-4 mg/day)" (1 trials). Other intervention names were less common.

The vast majority of trials in "OU Jaanson & Laane (EE0002)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "OU Jaanson & Laane (EE0002)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in OU Jaanson & Laane (EE0002), undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in OU Jaanson & Laane (EE0002), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".